Einstein Centre for Early Disease Interception

What if we could detect disease before symptoms appear? How might this change the future of healthcare? At the Einstein Center for Early Disease Interception (EC-EDI), researchers investigate how cells change even before the very first signs of illness. Using artificial intelligence and cutting-edge technology, we aim to stop diseases ‘upstream’ of symptoms, earlier than ever before.  

The Public Engagement and Impact team at the Museum für Naturkunde is a partner in this Center. As our biomedical, clinical and technical colleagues develop new technologies and diagnostics in ‘upstream medicine’, we advance ‘upstream engagement’, setting new standards in innovative teaching and education formats, science communication with patients and society, and productive communication with biomedical, industrial and political stakeholders.

Throughout the project, we will introduce science communication methods and public engagement frameworks that will mutually benefit all participants, support the applicability of our research, and evidence the societal relevance of our research.

Partners

The Einstein Center for Early Disease Interception is a consortium of 12 Berlin-based institutions. The other participating partners are:

• Charité - Universitätsmedizin Berlin

• Berlin Institute of Health

• Max Delbrück Center Berlin

• Freie Universität Berlin

• Technische Universität Berlin

• BIFOLD - Berlin Institute for the Foundations of Learning and Data

• Humboldt Universität zu Berlin

• German Rheumatology Research Center (DRFZ)

• Max Planck Unit for the Science of Pathogens

• Max Planck Institute for Molecular Genetics

• ICN Creative Business School